{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:14:02Z","timestamp":1787062442129,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clinph.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:29:47Z","timestamp":1600082987000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study"],"prefix":"10.1016","volume":"132","author":[{"given":"Vera","family":"Bril","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Philip","family":"Lawo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billie L.","family":"Durn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orell","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2020.09.001_b0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2020.09.001_b0010","first-page":"S91","article-title":"Guidelines in electrodiagnostic medicine. Recommended policy for electrodiagnostic medicine","volume":"8","author":"American Association of Electrodiagnostic Medicine","year":"1999","journal-title":"Muscle Nerve Suppl"},{"key":"10.1016\/j.clinph.2020.09.001_b0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1017\/S0317167100001013","article-title":"Minimum standards for electromyography in Canada: a statement of the Canadian Society of Clinical Neurophysiologists","volume":"27","author":"Bolton","year":"2000","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.clinph.2020.09.001_b0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mus.21733","article-title":"Electrophysiologic correlations with clinical outcomes in CIDP","volume":"42","author":"Bril","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.09.001_b0025","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1368::AID-MUS2>3.0.CO;2-7","article-title":"Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group","volume":"21","author":"Bril","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.09.001_b0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mus.21236","article-title":"Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV","volume":"39","author":"Bril","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.09.001_b0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(19)30144-9","article-title":"Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Bunschoten","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2020.09.001_b0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/mus.24624","article-title":"Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: comparison of patients with and without subsequent relapse","volume":"52","author":"Chin","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.09.001_b0045","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mus.26669","article-title":"Clinical-neurophysiological correlations in chronic inflammatory demyelinating polyradiculoneuropathy patients treated with subcutaneous immunoglobulin","volume":"60","author":"Cirillo","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2020.09.001_b0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.clinph.2018.01.070","article-title":"Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin","volume":"129","author":"Cirillo","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2020.09.001_b0055","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1212\/WNL.0000000000001044","article-title":"Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness","volume":"83","author":"Draak","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2020.09.001_b0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ana.410110205","article-title":"Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment","volume":"11","author":"Dyck","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2020.09.001_b0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1085-9489.2005.0010208.x","article-title":"Functional health status of patients with chronic inflammatory neuropathies","volume":"10","author":"Erdmann","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.clinph.2020.09.001_b0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2020.09.001_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8027.2010.00245.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.clinph.2020.09.001_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000505234","article-title":"Electrophysiological responsiveness to long-term therapy in chronic inflammatory demyelinating polyneuropathy: case report","volume":"12","author":"Khomand","year":"2020","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.clinph.2020.09.001_b0085","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinph.2020.09.001_b0090","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.clinph.2019.06.231","article-title":"Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins","volume":"130","author":"Lawley","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2020.09.001_b0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.54.4.943","article-title":"Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group","volume":"54","author":"Merkies","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2020.09.001_b0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinph.2020.09.001_b0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/jns.12118","article-title":"Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison","volume":"20","author":"Vanhoutte","year":"2015","journal-title":"J Peripher Nerv Syst"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245720304697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245720304697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:04:34Z","timestamp":1761393874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245720304697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1388245720304697"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2020.09.001","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}